Myocardial infarction, year of event |
28,968 |
[22] |
Myocardial infarction, subsequent years |
4,176 |
[22] |
Angina, each year |
19,177 |
[23] |
Congestive heart failure, year of onset |
38,584 |
[22] |
Congestive heart failure, subsequent year |
16,143 |
[22] |
Stroke, year of event |
34,812 |
[22] |
Stroke, subsequent years |
9,169 |
[22] |
Stroke death within 30 days |
35,195 |
[22] |
Peripheral vascular disease, year of onset |
27,974 |
[24] |
Peripheral vascular disease, subsequent years |
5,320 |
[24] |
Hemodialysis, each year |
92,331 |
[25] |
Peritoneal dialysis, year of onset |
93,761 |
[25] |
Peritoneal dialysis, subsequent year |
58,555 |
[25] |
Renal transplant, year of event |
81,549 |
[26] |
Renal transplant, subsequent years |
11,770 |
[26] |
Laser treatment |
465 |
[27] |
Severe vision loss/blindness, year of onset |
22,062 |
[22] |
Severe vision loss/blindness, subsequent year |
7550 |
[22] |
Cataract extraction |
784 |
[28] |
Cataract treatment, subsequent year |
280 |
[29] |
Neuropathy, each year |
250 |
[30] |
Infected foot ulcer |
38,293 |
[22] |
Gangrene treatment |
266.95 |
[31] |
Amputation, year of event |
50,723 |
[22] |
Severe hypoglycaemic event requiring medical assistance |
4195 |
[32] |
Aspirin, annual cost |
46.08 |
[33] |
Statins (20 mg), annual cost |
176.78 |
[34] |
Angiotensin converting enzyme inhibitor (Ramipril 5 mg), annual cost |
175.50 |
[35] |
Screening for retinopathy |
61.20 |
[36] |
Screening for microalbuminuria |
61.20 |
[36] |
Screening for gross proteinuria |
61.20 |
[36] |